CAPTRUST Financial Advisors
USNA icon

CAPTRUST Financial Advisors’s Usana Health Sciences USNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,103
Closed -$80K – 3962
2022
Q2 		$80K Buy
1,103
+564
+105% +$42K ﹤0.01% 2381
2022
Q1 		$43K Sell
539
-48
-8% -$4.33K ﹤0.01% 2905
2021
Q4 		$59K Sell
587
-103
-15% -$10.3K ﹤0.01% 2552
2021
Q3 		$64K Sell
690
-10
-1% -$962 ﹤0.01% 2419
2021
Q2 		$72K Hold
700
– – ﹤0.01% 2268
2021
Q1 		$68K Buy
700
+680
+3,400% +$61.9K ﹤0.01% 2227
2020
Q4 		$2K Hold
20
– – ﹤0.01% 3162
2020
Q3 		$1K Buy
+20
New +$1.6K ﹤0.01% 2962

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CAPTRUST Financial Advisors's USNA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 1,103 shares — an estimated $80K sold.

CAPTRUST Financial Advisors first reported a position in USNA in Q3 2020 and held it in 8 quarters. The position peaked at $80K in Q2 2022. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,103 Usana Health Sciences shares in Q3 2022, an estimated $80K.
  • CAPTRUST Financial Advisors first reported a position in Usana Health Sciences in Q3 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Usana Health Sciences position peaked at $80K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.